Andrew Vernon - Concepedia

Concepedia

Author

Andrew Vernon

Centers for Disease Control and Prevention

Also Known As

A N Vernon, A. Vernon, ANDREW VERNON, Andrew N. Vernon, Andrew Vernon

14

Publications

1.6K

Citations

11

H-Index

17

Concepts

All Affiliations

Centers for Disease Control and Prevention Sorbonne Université Denver Health Medical Center University of Colorado Denver

AV

About

Andrew Vernon is an author at Centers for Disease Control and Prevention specializing in tuberculosis, medicine, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.2K
2	Pharmacology	2	2	725
3	Antibiotics	2	2	626
4	Health Sciences	1	1	184
5	Public Health	1	1	184

Andrew Vernon

×

10

Publications

1.6K

Citations

10

H-Index

	Year	Citations
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial Debra Benator, Mondira Bhattacharya, Lorna Bozeman, The Lancet Pulmonary TuberculosisTreatment And PreventionMedicineRandomised Clinical TrialWeek Versus Rifampicin	2002	408
Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis Eric L. Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, American Journal of Respiratory and Critical Care Medicine New DrugPulmonary TuberculosisTuberculosis Control ProgramsAntibioticsMedicine	2003	317
Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid Andrew Vernon, William J. Burman, Debra Benator, The Lancet AntibioticsHiv-related TuberculosisTuberculosisAntimicrobial ChemotherapyAcquired Rifamycin Monoresistance	1999	309
Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial Awal Khan, Timothy R. Sterling, Randall Reves, American Journal of Respiratory and Critical Care Medicine ObesityPulmonary TuberculosisBody CompositionBody Mass IndexTuberculosis Prevention	2006	184
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults John L. Johnson, Alphonse Okwera, David L. Hom, AIDS	2001	154
Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against <i>Mycobacterium tuberculosis</i> in Mice Nacer Lounis, Abdelhalim Bentoucha, C. Truffot-Pernot, Antimicrobial Agents and Chemotherapy	2001	80
The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse. Carol Hamilton, Jason E. Stout, Philip C. Goodman, PubMed	2008	49
Isoniazid-associated Hepatitis and Antiretroviral Drugs during Tuberculosis Prophylaxis in HIV-infected Adults in Botswana Zegabriel Tedla, Samba Nyirenda, Crandall E. Peeler, American Journal of Respiratory and Critical Care Medicine	2010	43
Antituberculosis Activity of Once-weekly Rifapentine-containing Regimens in Mice Nathalie Daniel, Nacer Lounis, Baohong Ji, American Journal of Respiratory and Critical Care Medicine	2000	31
Pleural Effusion Resulting from Metastatic Papillary Carcinoma of the Thyroid Andrew Vernon, Leslie R. Sheeler, Charles V. Biscotti, CHEST Journal Thyroid DiseasePleural EffusionPleural Disease	1992	26

Page 1